ClinicalTrials.Veeva

Menu

To Achieve an Early Reendothelialization at the Expense of Low Restenosis: The EREMUS Study

O

Ospedale della Misericordia

Status and phase

Unknown
Phase 4

Conditions

Angioplasty, Transluminal, Percutaneous Coronary
Percutaneous Coronary Intervention

Treatments

Device: Percutaneous coronary intervention: Uncoated balloon + Genous stent
Device: Percutaneous coronary intervention: Paclitaxel eluting balloon (Elutax) + Genous stent
Device: Percutaneous coronary intervention: Drug eluting stent (Taxus stent)

Study type

Interventional

Funder types

Other

Identifiers

NCT00870038
Bernard1

Details and patient eligibility

About

The investigators sought to discover which one of the following strategies is the safest for patients undergoing percutaneous coronary intervention: paclitaxel-coated balloon+Genous stent; Genous stent; drug eluting stent (paclitaxel).

Enrollment

75 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Stable or unstable angina pectoris suitable to PCI of at least one coronary vessel
  • Age >18 years

Exclusion criteria

  • Recent (<72 hours) acute myocardial infarction
  • Creatinine clearance <40 ml/min
  • Allergy or hypersensitivity to at least two between: aspirin, clopidogrel, heparin, bivalirudin, paclitaxel, contrast media
  • Life expectancy <1 year

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

75 participants in 3 patient groups

1
Experimental group
Description:
Paclitaxel eluting balloon (Elutax) + Genous stent
Treatment:
Device: Percutaneous coronary intervention: Paclitaxel eluting balloon (Elutax) + Genous stent
2
Experimental group
Description:
Uncoated balloon + Genous stent
Treatment:
Device: Percutaneous coronary intervention: Uncoated balloon + Genous stent
3
Active Comparator group
Description:
Drug eluting stent (Taxus stent)
Treatment:
Device: Percutaneous coronary intervention: Drug eluting stent (Taxus stent)

Trial contacts and locations

1

Loading...

Central trial contact

Bernardo Cortese, MD; Ugo Limbruno, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems